Semaglutide as a promising antiobesity drug-Reference-Cited by-同舟云学术

Semaglutide as a promising antiobesity drug

Published:2019-02-15 Issue:6 Volume:20 Page:805-815
ISSN:1467-7881
Container-title:Obesity Reviews
language:en
Short-container-title:Obesity Reviews

Author:

Christou Georgios A.¹,Katsiki Niki²,Blundell John³,Fruhbeck Gema⁴,Kiortsis Dimitrios N.¹^ORCID

Affiliation:

1. School of Medicine; University of Ioannina; Ioannina Greece

2. Second Propedeutic Department of Internal Medicine, Medical School; Aristotle University of Thessaloniki, Hippocration Hospital; Thessaloniki Greece

3. Institute of Psychological Sciences, Faculty of Medicine and Health; University of Leeds; Leeds UK

4. Metabolic Research Laboratory; Clinica Universidad de Navarra, CIBEROBN; Pamplona Spain

Publisher

Wiley

Subject

Public Health, Environmental and Occupational Health,Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/obr.12839/fullpdf

Reference104 articles.

1. Pharmacotherapy of type 2 diabetes: an update;Upadhyay;Metabolism,2018

2. Liraglutide and cardiovascular outcomes in type 2 diabetes;Marso;N Engl J Med,2016

3. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes;Marso;N Engl J Med,2016

4. The current role of liraglutide in the pharmacotherapy of obesity;Christou;Curr Vasc Pharmacol,2016

5. Liraglutide and cardiometabolic effects: more than just another antiobesity drug?;Katsiki;Curr Vasc Pharmacol,2016

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obesity: exploring its connection to brain function through genetic and genomic perspectives;Molecular Psychiatry;2024-09-05

2. Approved and Emerging Hormone-Based Anti-Obesity Medications: A Review Article;Indian Journal of Endocrinology and Metabolism;2024-09-04

3. Tirzepatide: unveiling a new dawn in dual-targeted diabetes and obesity management;Expert Review of Endocrinology & Metabolism;2024-08-28

4. Effect of Semaglutide in Individuals With Obesity or Overweight Without Diabetes;Cureus;2024-08-27

5. Mechanisms of Non-alcoholic Fatty Liver Disease and Beneficial Effects of Semaglutide: A Review;Cureus;2024-08-17